{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T07:47:35Z","timestamp":1758268055433,"version":"3.37.3"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2016,9,8]],"date-time":"2016-09-08T00:00:00Z","timestamp":1473292800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100005010","name":"AIRC","doi-asserted-by":"crossref","award":["IG15420"],"award-info":[{"award-number":["IG15420"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Comput Aided Mol Des"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1007\/s10822-016-9962-8","type":"journal-article","created":{"date-parts":[[2016,9,8]],"date-time":"2016-09-08T09:29:35Z","timestamp":1473326975000},"page":"851-861","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Structure-based approach for identification of novel phenylboronic acids as serine-\u03b2-lactamase inhibitors"],"prefix":"10.1007","volume":"30","author":[{"given":"Jacopo","family":"Sgrignani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Filomena","family":"De Luca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hayarpi","family":"Torosyan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Denis","family":"Docquier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Da","family":"Duan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatrice","family":"Novati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabio","family":"Prati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giorgio","family":"Colombo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3261-9356","authenticated-orcid":false,"given":"Giovanni","family":"Grazioso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,9,8]]},"reference":[{"issue":"20065329","key":"9962_CR1","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1128\/CMR.00037-09","volume":"23","author":"SM Drawz","year":"2010","unstructured":"Drawz SM, Bonomo RA (2010) Three decades of beta-lactamase inhibitors. Clin Microbiol Rev 23(20065329):160\u2013201","journal-title":"Clin Microbiol Rev"},{"key":"9962_CR2","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1128\/AAC.00826-13","volume":"58","author":"SM Drawz","year":"2014","unstructured":"Drawz SM, Papp-Wallace KM, Bonomo RA (2014) New beta-lactamase inhibitors: a therapeutic renaissance in an MDR world. Antimicrob Agents Chemother 58:1835\u20131846","journal-title":"Antimicrob Agents Chemother"},{"key":"9962_CR3","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.2174\/09298673113206660323","volume":"21","author":"D Farina","year":"2014","unstructured":"Farina D, Spyrakis F, Venturelli A, Cross S, Tondi D, Costi MP (2014) Curr Med Chem 21:1405\u20131434","journal-title":"Curr Med Chem"},{"key":"9962_CR4","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1098\/rstb.1980.0049","volume":"289","author":"RP Ambler","year":"1980","unstructured":"Ambler RP (1980) Philos Trans R Soc Lond Ser B Biol Sci 289:321\u2013331","journal-title":"Philos Trans R Soc Lond Ser B Biol Sci"},{"key":"9962_CR5","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1179\/2047773215Y.0000000030","volume":"109","author":"F Prestinaci","year":"2015","unstructured":"Prestinaci F, Pezzotti P, Pantosti A (2015) Antimicrobial resistance: a global multifaceted phenomenon. Pathog Glob Health 109:309\u2013318","journal-title":"Pathog Glob Health"},{"key":"9962_CR6","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1093\/jac\/dkn320","volume":"62","author":"DM Livermore","year":"2008","unstructured":"Livermore DM, Mushtaq S, Warner M, Miossec C, Woodford N (2008) NXL104 combinations versus Enterobacteriaceae with CTX-M extended-spectrum beta-lactamases and carbapenemases. J Antimicrob Chemother 62:1053\u20131056","journal-title":"J Antimicrob Chemother"},{"key":"9962_CR7","doi-asserted-by":"crossref","first-page":"3753","DOI":"10.1128\/AAC.05927-11","volume":"56","author":"EB Hirsch","year":"2012","unstructured":"Hirsch EB, Ledesma KR, Chang KT, Schwartz MS, Motyl MR, Tam VH (2012) In vitro activity of MK-7655, a novel beta-lactamase inhibitor, in combination with imipenem against carbapenem-resistant gram-negative bacteria. Antimicrob Agents Chemother 56:3753\u20133757","journal-title":"Antimicrob Agents Chemother"},{"key":"9962_CR8","doi-asserted-by":"crossref","first-page":"3682","DOI":"10.1021\/acs.jmedchem.5b00127","volume":"58","author":"SJ Hecker","year":"2015","unstructured":"Hecker SJ, Reddy KR, Totrov M, Hirst GC, Lomovskaya O, Griffith DC, King P, Tsivkovski R, Sun D, Sabet M, Tarazi Z, Clifton MC, Atkins K, Raymond A, Potts KT, Abendroth J, Boyer SH, Loutit JS, Morgan EE, Durso S, Dudley MN (2015) Discovery of a cyclic boronic acid beta-lactamase inhibitor (RPX7009) with utility vs class A serine carbapenemases. J Med Chem 58:3682\u20133692","journal-title":"J Med Chem"},{"key":"9962_CR9","first-page":"2286","volume":"68","author":"DM Livermore","year":"2013","unstructured":"Livermore DM, Warner M, Mushtaq S (2013) Activity of MK-7655 combined with imipenem against Enterobacteriaceae and Pseudomonas aeruginosa. J Antimicrob Chemother 68:2286\u20132290","journal-title":"J Antimicrob Chemother"},{"unstructured":"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01897779","key":"9962_CR10"},{"key":"9962_CR11","doi-asserted-by":"crossref","first-page":"4577","DOI":"10.1021\/jm980343w","volume":"41","author":"GS Weston","year":"1998","unstructured":"Weston GS, Blazquez J, Baquero F, Shoichet BK (1998) Structure-based enhancement of boronic acid-based inhibitors of AmpC beta-lactamase. J Med Chem 41:4577\u20134586","journal-title":"J Med Chem"},{"key":"9962_CR12","doi-asserted-by":"crossref","first-page":"5449","DOI":"10.1021\/jm5006572","volume":"57","author":"D Tondi","year":"2014","unstructured":"Tondi D, Venturelli A, Bonnet R, Pozzi C, Shoichet BK, Costi MP (2014) Targeting class A and C serine \u03b2-lactamases with a broad-spectrum boronic acid derivative. J Med Chem 57:5449\u20135458","journal-title":"J Med Chem"},{"key":"9962_CR13","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1021\/ja0288338","volume":"125","author":"F Morandi","year":"2003","unstructured":"Morandi F, Caselli E, Morandi S, Focia PJ, Blazquez J, Shoichet BK, Prati F (2003) Nanomolar inhibitors of AmpC beta-lactamase. J Am Chem Soc 125:685\u2013695","journal-title":"J Am Chem Soc"},{"key":"9962_CR14","doi-asserted-by":"crossref","first-page":"17448","DOI":"10.1073\/pnas.1208337109","volume":"109","author":"O Eidam","year":"2012","unstructured":"Eidam O, Romagnoli C, Dalmasso G, Barelier S, Caselli E, Bonnet R, Shoichet BK, Prati F (2012) Fragment-guided design of subnanomolar beta-lactamase inhibitors active in vivo. Proc Natl Acad Sci USA 109:17448\u201317453","journal-title":"Proc Natl Acad Sci USA"},{"key":"9962_CR15","doi-asserted-by":"crossref","first-page":"8434","DOI":"10.1021\/bi034242y","volume":"42","author":"X Wang","year":"2003","unstructured":"Wang X, Minasov G, Blazquez J, Caselli E, Prati F, Shoichet BK (2003) Recognition and resistance in TEM beta-lactamase. Biochemistry 42:8434\u20138444","journal-title":"Biochemistry"},{"key":"9962_CR16","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1038\/nchembio.1666","volume":"10","author":"N London","year":"2014","unstructured":"London N, Miller RM, Krishnan S, Uchida K, Irwin JJ, Eidam O, Gibold L, Cimermancic P, Bonnet R, Shoichet BK, Taunton J (2014) Covalent docking of large libraries for the discovery of chemical probes. Nat Chem Biol 10:1066\u20131072","journal-title":"Nat Chem Biol"},{"key":"9962_CR17","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s10822-015-9834-7","volume":"29","author":"J Sgrignani","year":"2015","unstructured":"Sgrignani J, Novati B, Colombo G, Grazioso G (2015) Covalent docking of selected boron-based serine beta-lactamase inhibitors. J Comput Aided Mol Des 29:441\u2013450","journal-title":"J Comput Aided Mol Des"},{"unstructured":"http:\/\/www.sigmaaldrich.com\/chemistry\/chemistry-services\/selected-structure.html . Accessed 18 Apr 2014","key":"9962_CR18"},{"key":"9962_CR19","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1042\/bj2090229","volume":"209","author":"T Beesley","year":"1983","unstructured":"Beesley T, Gascoyne N, Knott-Hunziker V, Petursson S, Waley SG, Jaurin B, Grundstr\u00f6m T (1983) The inhibition of class C \u03b2-lactamases by boronic acids. Biochem J 209:229\u2013233","journal-title":"Biochem J"},{"key":"9962_CR20","doi-asserted-by":"crossref","first-page":"3416","DOI":"10.1016\/j.bmcl.2010.04.007","volume":"20","author":"D Tondi","year":"2010","unstructured":"Tondi D, Cal\u00f2 S, Shoichet BK, Costi MP (2010) Structural study of phenyl boronic acid derivatives as AmpC \u03b2-lactamase inhibitors. Bioorg Med Chem Lett 20:3416\u20133419","journal-title":"Bioorg Med Chem Lett"},{"key":"9962_CR21","doi-asserted-by":"crossref","first-page":"7757","DOI":"10.1021\/bi00023a023","volume":"34","author":"A Dubus","year":"1995","unstructured":"Dubus A, Normark S, Kania M, Page MG (1995) Role of asparagine 152 in catalysis of beta-lactam hydrolysis by Escherichia coli AmpC beta-lactamase studied by site-directed mutagenesis. Biochemistry 34:7757\u20137764","journal-title":"Biochemistry"},{"key":"9962_CR22","doi-asserted-by":"crossref","first-page":"3222","DOI":"10.1021\/jm020002p","volume":"45","author":"RA Powers","year":"2002","unstructured":"Powers RA, Shoichet BK (2002) Structure-based approach for binding site identification on AmpC beta-lactamase. J Med Chem 45:3222\u20133234","journal-title":"J Med Chem"},{"key":"9962_CR23","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1021\/acsinfecdis.5b00031","volume":"1","author":"DC McKinney","year":"2015","unstructured":"McKinney DC, Zhou F, Eyermann CJ, Ferguson AD, Prince DB, Breen J, Giacobbe RA, Lahiri S, Verheijen JC (2015) 4,5-disubstituted 6-aryloxy-1,3-dihydrobenzo[c][1, 2]oxaboroles are broad-spectrum serine \u03b2-lactamase inhibitors. ACS Infect Dis 1:310\u2013316","journal-title":"ACS Infect Dis"},{"key":"9962_CR24","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1107\/S0907444912024080","volume":"68","author":"JF Ruble","year":"2012","unstructured":"Ruble JF, Lefurgy ST, Cornish VW, Powers RA (2012) Structural analysis of the Asn152Gly mutant of P99 cephalosporinase. Acta Crystallogr D 68:1189\u20131193","journal-title":"Acta Crystallogr D"},{"key":"9962_CR25","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1128\/AAC.06099-11","volume":"56","author":"W Ke","year":"2012","unstructured":"Ke W, Bethel CR, Papp-Wallace KM, Pagadala SR, Nottingham M, Fernandez D, Buynak JD, Bonomo RA, van den Akker F (2012) Crystal structures of KPC-2 beta-lactamase in complex with 3-nitrophenyl boronic acid and the penam sulfone PSR-3-226. Antimicrob Agents Chemother 56:2713\u20132718","journal-title":"Antimicrob Agents Chemother"},{"key":"9962_CR26","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1006\/jmbi.1996.0897","volume":"267","author":"G Jones","year":"1997","unstructured":"Jones G, Willett P, Glen RC, Leach AR, Taylor R (1997) Development and validation of a genetic algorithm for flexible docking. J Mol Biol 267:727\u2013748","journal-title":"J Mol Biol"},{"key":"9962_CR27","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1021\/jm061277y","volume":"50","author":"MJ Hartshorn","year":"2007","unstructured":"Hartshorn MJ, Verdonk ML, Chessari G, Brewerton SC, Mooij WT, Mortenson PN, Murray CW (2007) Diverse, high-quality test set for the validation of protein-ligand docking performance. J Med Chem 50:726\u2013741","journal-title":"J Med Chem"},{"key":"9962_CR28","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1002\/jcc.540100804","volume":"10","author":"M Clark","year":"1989","unstructured":"Clark M, Cramer RD, Van Opdenbosch N (1989) Validation of the general purpose tripos 5.2 force field. J Comput Chem 10:982\u20131012","journal-title":"J Comput Chem"},{"key":"9962_CR29","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1021\/ci800298z","volume":"49","author":"O Korb","year":"2009","unstructured":"Korb O, Stutzle T, Exner TE (2009) Empirical scoring functions for advanced protein-ligand docking with PLANTS. J Chem Inf Mod 49:84\u201396","journal-title":"J Chem Inf Mod"},{"key":"9962_CR30","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/BF02289588","volume":"32","author":"SC Johnson","year":"1967","unstructured":"Johnson SC (1967) Hierarchical clustering schemes. Psychometrika 32:241\u2013254","journal-title":"Psychometrika"},{"key":"9962_CR31","doi-asserted-by":"crossref","first-page":"3197","DOI":"10.1128\/AAC.01336-09","volume":"54","author":"L Borgianni","year":"2010","unstructured":"Borgianni L, Vandenameele J, Matagne A, Bini L, Bonomo RA, Fr\u00e8re JM, Rossolini GM, Docquier JD (2010) Mutational analysis of VIM-2 reveals an essential determinant for metallo-beta-lactamase stability and folding. Antimicrob Agents Chemother 54:3197\u20133204","journal-title":"Antimicrob Agents Chemother"},{"key":"9962_CR32","doi-asserted-by":"crossref","first-page":"18424","DOI":"10.1073\/pnas.1110530108","volume":"108","author":"F Luca De","year":"2011","unstructured":"De Luca F, Benvenuti M, Carboni F, Pozzi C, Rossolini GM, Mangani S, Docquier JD (2011) Evolution to carbapenem-hydrolyzing activity in noncarbapenemase class D \u03b2-lactamase OXA-10 by rational protein design. Proc Natl Acad Sci USA 108:18424\u201318429","journal-title":"Proc Natl Acad Sci USA"},{"unstructured":"De Luca F, Rossolini GM, Docquier JD (2015) In: ASM Press (ed) 55th Interscience conference on antimicrobial agents and chemotherapy, ICAAC\/ICC 2015. Washington DC, San Diego, CA","key":"9962_CR33"},{"key":"9962_CR34","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.chembiol.2009.04.010","volume":"16","author":"JD Docquier","year":"2009","unstructured":"Docquier JD, Calderone V, De Luca F, Benvenuti M, Giuliani F, Bellucci L, Tafi A, Nordmann P, Botta M, Rossolini GM, Mangani S (2009) Crystal structure of the OXA-48 beta-lactamase reveals mechanistic diversity among class D carbapenemases. Chem Biol 16:540\u2013547","journal-title":"Chem Biol"},{"key":"9962_CR35","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1128\/AAC.02247-12","volume":"57","author":"SD Lahiri","year":"2013","unstructured":"Lahiri SD, Mangani S, Durand-Reville T, Benvenuti M, De Luca F, Sanyal G, Docquier JD (2013) Structural insight into potent broad-spectrum inhibition with reversible recyclization mechanism: avibactam in complex with CTX-M-15 and Pseudomonas aeruginosa AmpC \u03b2-lactamases. Antimicrob Agents Chemother 57:2496\u20132505","journal-title":"Antimicrob Agents Chemother"},{"key":"9962_CR36","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1128\/AAC.46.6.1823-1830.2002","volume":"46","author":"JD Docquier","year":"2002","unstructured":"Docquier JD, Pantanella F, Giuliani F, Thaller MC, Amicosante G, Galleni M, Frere JM, Bush K, Rossolini GM (2002) CAU-1, a subclass B3 metallo-beta-lactamase of low substrate affinity encoded by an ortholog present in the Caulobacter crescentus chromosome. Antimicrob Agents Chemother 46:1823\u20131830","journal-title":"Antimicrob Agents Chemother"},{"key":"9962_CR37","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1093\/jac\/dkg067","volume":"51","author":"JD Docquier","year":"2003","unstructured":"Docquier JD, Lamotte-Brasseur J, Galleni M, Amicosante G, Frere JM, Rossolini GM (2003) On functional and structural heterogeneity of VIM-type metallo-beta-lactamases. J Antimicrob Chemother 51:257\u2013266","journal-title":"J Antimicrob Chemother"}],"container-title":["Journal of Computer-Aided Molecular Design"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-016-9962-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10822-016-9962-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-016-9962-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T04:46:02Z","timestamp":1589690762000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10822-016-9962-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,8]]},"references-count":37,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["9962"],"URL":"https:\/\/doi.org\/10.1007\/s10822-016-9962-8","relation":{},"ISSN":["0920-654X","1573-4951"],"issn-type":[{"type":"print","value":"0920-654X"},{"type":"electronic","value":"1573-4951"}],"subject":[],"published":{"date-parts":[[2016,9,8]]}}}